(E)-N'-Butyl-N-[3-(trifluoromethyl)phenyl]pyridine-3-carboximidamide

Catalog No. :
ACICWL930
CAS No. :
338420-51-2
Molecular Formula :
C17H18F3N3
Molecular Weight :
321.35

IUPAC Name:N'-butyl-N-(3-(trifluoromethyl)phenyl)nicotinimidamide

(E)-N'-Butyl-N-[3-(trifluoromethyl)phenyl]pyridine-3-carboximidamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-N'-Butyl-N-[3-(trifluoromethyl)phenyl]pyridine-3-carboximidamide
IUPAC NameN'-butyl-N-(3-(trifluoromethyl)phenyl)nicotinimidamide
MDL No.MFCD00171863
Molecular FormulaC17H18F3N3
Molecular Weight321.35
SMILESFC(C1=CC(N/C(C2=CC=CN=C2)=N/CCCC)=CC=C1)(F)F
InChI KeyWPUXYAGYAZOGBG-UHFFFAOYSA-N
SynonymN'-BUTYL-N-[3-(TRIFLUOROMETHYL)PHENYL]-3-PYRIDINECARBOXIMIDAMIDE;(E)-N'-butyl-N-[3-(trifluoromethyl)phenyl]pyridine-3-carboximidamide;3-Pyridinecarboximidamide, N-butyl-N'-[3-(trifluoromethyl)phenyl]-
CAS No.338420-51-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACICWL930 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAENY278 route compound structure diagram
    ACAENY27815567-09-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACICWL930 route product structure diagram
    ACICWL930338420-51-2
Inquiry

2. ACICWL930 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRAUC529 route compound structure diagram
    ACRAUC5292646-97-1 In Stock
  4. Then
  5. ACICWL930 route product structure diagram
    ACICWL930338420-51-2
Inquiry

Comments (0)